Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Frequently asked questions
What sector does Insulet Corporation (GOV) operate in?
Insulet Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Insulet Corporation (GOV) current stock price?
As of the latest data, Insulet Corporation stock price is €132.90, with a previous close of €132.25. Insulet Corporation gained €0.65 in the last trading session, representing a 0.49% increase.
What is Insulet Corporation (GOV) current market capitalization?
Insulet Corporation market cap is approximately 9.22 billion.
What is Insulet Corporation (GOV) Earnings Per Share (EPS)?
The trailing EPS is €4.58.
What is Insulet Corporation (GOV) Price-to-Earnings (P/E) ratio?
Insulet Corporation current P/E ratio is 29.02.
What is Insulet Corporation (GOV) EBITDA?
Insulet Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 139.12 million.
Does Insulet Corporation (GOV) pay dividends?
No. Insulet Corporation does not pay a dividend.
When is Insulet Corporation (GOV) next earnings report?
Insulet Corporation is expected to release its next earnings report on September 30, 2026.
What is Insulet Corporation (GOV) beta (volatility) score?
Insulet Corporation has a beta of 1.101, meaning its volatility is roughly in line with the market.
